Life Science Leader — April 2013 Outsourcing and the oral solid dose: Will challenges lead to new patterns of outsourcing? Life Science Leader — CRO Leadership Awards supplement issue Strategic Outsourcing Often Means Combining Functional and Full-Service CROs 
 
May 10 Life Science Leader's May issue includes results from Nice Insight annual research April 10 Learn about Trends in Outsourcing the Oral Solid Dose in April's Outsourcing Insights 
"This is an invaluable resource that allowed me to become more aware of all
of the global biotechnology outsourcing companies that are out there."
Executive Director Of Manufacturing and Science Technology; Biotechnology, Asia  
DIA 2013 49th Annual Meeting
June 23-27 Boston, MA |
Ajinomoto AminoScience Amsyn Asymchem Laboratories Inc. Halo Pharmaceutical Inc. McGean Johnson Matthey Pharma Services
Johnson Matthey Pharma Services, a subsidiary of Johnson Matthey plc, is a global supplier of APIs, fine chemicals and other specialty chemical products and services to chemical and pharmaceutical companies and industrial and academic research organizations. The company provides solutions for complex molecules such as separation technologies, asymmetric/chiral development and analytical technologies, and catalytic process screening. Specializing in the manufacture of platinum-based anticancer APIs and controlled drugs, the company’s services include designing, developing, and optimizing synthetic routes; producing and/or scaling up intermediates and API’s; and process development, process validation, and commercial manufacturing. http://www.jmpharmaservices.com
Regions
Americas, Europe Stock Symbol Private Filter of Johnson Matthey Pharma Services's services per Nice Insight Categories
Contact Johnson Matthey Pharma Services 
|
|
|
